Ohio Public Health Reporting Enrollment
Data Exchange Requirements
View Data Exchange Process Documentation
Download HL7 2.5.1 Implementation Guide For Immunization Messaging
Ohio HL7 2.5.1 Fields in Excel
HL7 Codesets
Helpful Links
Ohio Department of Health - Meaningful Use
Ohio Department of Job and Family Services - Meaningful Use
CMS Electronic Health Record Incentive Program
Additional Information
HL7 2.5.1 - CVX CodeSet - HL70292
| Value | Description |
|---|---|
| 03 | MMR |
| 06 | rubella |
| 07 | mumps |
| 08 | Hep B, adolescent or pediatric |
| 09 | Td (adult), adsorbed |
| 10 | IPV |
| 101 | typhoid, ViCPs |
| 104 | Hep A-Hep B |
| 106 | DTaP, 5 pertussis antigens |
| 110 | DTaP-Hep B-IPV |
| 113 | Td (adult) preservative free |
| 114 | meningococcal MCV4P |
| 115 | Tdap |
| 116 | rotavirus, pentavalent |
| 118 | HPV, bivalent |
| 119 | rotavirus, monovalent |
| 12 | diphtheria antitoxin |
| 120 | DTaP-Hib-IPV |
| 121 | zoster |
| 13 | TIG |
| 130 | DTap-IPV |
| 133 | Pneumococcal conjugate PCV 13 |
| 134 | Japanese Encephalitis IM |
| 135 | Influenza, high dose seasonal |
| 136 | Meningococcal MCV4O |
| 138 | Td (adult) |
| 140 | Influenza, seasonal, injectable, preservative free |
| 141 | Influenza, seasonal, injectable |
| 142 | tetanus toxoid,not adsorbed |
| 143 | Adenovirus types 4 and 7 |
| 144 | Influenza, seasonal, intradermal, preservative free |
| 148 | Meningococcal C/Y-HIB PRP |
| 149 | influenza, live, intranasal, quadrivalent |
| 150 | influenza, injectable, quadrivalent, preservative free |
| 153 | Influenza, injectable, MDCK, preservative free |
| 155 | influenza, recombinant, injectable, preservative free |
| 156 | Rho(D)-IG |
| 157 | Rho(D) -IG IM |
| 158 | influenza, injectable, quadrivalent |
| 160 | Influenza A monovalent (H5N1), ADJUVANTED-2013 |
| 161 | Influenza, injectable,quadrivalent, preservative free, pediatric |
| 162 | meningococcal B, recombinant |
| 163 | meningococcal B, OMV |
| 165 | HPV9 |
| 166 | influenza, intradermal, quadrivalent, preservative free |
| 18 | rabies, intramuscular injection |
| 19 | BCG |
| 20 | DTap |
| 21 | varicella |
| 23 | plague |
| 24 | anthrax |
| 25 | typhoid, oral |
| 27 | botulinum antitoxin |
| 28 | DT (pediatric) |
| 29 | CMVIG |
| 30 | HBIG |
| 32 | meningococcal MPSV4 |
| 33 | pneumococcal polysaccharide PPV23 |
| 34 | RIG |
| 35 | tetanus toxoid, adsorbed |
| 36 | VZIG |
| 37 | yellow fever |
| 39 | Japanese encephalitis SC |
| 40 | rabies, intradermal injection |
| 41 | typhoid, parenteral |
| 43 | Hep B, adult |
| 44 | Hep B, dialysis |
| 48 | Hib (PRP-T) |
| 49 | Hib (PRP-OMP) |
| 50 | DTap-Hib |
| 51 | Hib-Hep B |
| 52 | Hep A,adult |
| 53 | typhoid, parenteral, AKD (U.S. military) |
| 62 | HPV, quadrivalent |
| 71 | RSV-IGIV |
| 75 | vaccinia (smallpox) |
| 79 | vaccinia immune globulin |
| 8 | Hep B, adolescent or pediatric |
| 801 | AS03 Adjuvant |
| 83 | Hep A, ped/adol, 2 dose |
| 86 | IG |
| 87 | IGIV |
| 88 | influenza, unspecified formulation |
| 93 | RSV-MAb |
| 94 | MMRV |